Affordable Access

Publisher Website

Mutation of gene for mannose-binding protein associated with chronic hepatitis B viral infection

The Lancet
Publication Date
DOI: 10.1016/s0140-6736(96)05409-8
  • Primary Research
  • Early Report
  • Biology
  • Medicine


Summary Background Persistent infection with hepatitis B virus (HBV) affects 350 million people worldwide, and 20–40% of infected patients die of cirrhosis and liver cancer. Little is known about the host factors that determine the variable natural history. Studies have focused on the role of acquired rather than innate immunity. We have investigated the prevalence of mutations in the gene for mannose-binding protein (MBP), which have been associated with susceptibility to bacterial and fungal infections. Methods Mutations in the MBP gene were sought by sequence-specific oligonucleotide hybridisation, site-directed mutagenesis polymerase chain amplification, and direct sequencing in Caucasian and Asian patients with HBV infection, and in HBsAg-negative controls. Findings A mutation in codon 52 of the MBP gene was present in two (11%) of 19 Caucasian patients with acute hepatitis B and nine (27%) of 33 Caucasian patients with chronic hepatitis B, compared with four (4%) of 98 Caucasian controls (p=0·0004). By contrast, the prevalence of the mutation was similar in Asian patients with chronic hepatitis B and in Asian controls (one [5%] of 20 vs two [2%] of 117). Mutations in codon 54 and codon 57 were found in similar proportions of patients and controls. Interpretation These findings show in Caucasian, but not Asian, patients an association of the codon 52 mutation of the MBP gene with persistent HBV infection. They suggest an important role for this gene, or a gene in linkage disequilibrium with MBP, in determining outcome after HBV infection in adult but not neonatal life.

There are no comments yet on this publication. Be the first to share your thoughts.